Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

NCT00954447 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1263

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Placebo
DRUG: Linagliptin

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]